These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 8743003

  • 1. A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study.
    Simpson AJ, Gray TB, Ballantyne C.
    Aust N Z J Ophthalmol; 1996 Feb; 24(1):39-42. PubMed ID: 8743003
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [Abstract] [Full Text] [Related]

  • 4. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
    Strahlman E, Tipping R, Vogel R.
    Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1998 Oct; 105(10):1936-44. PubMed ID: 9787367
    [Abstract] [Full Text] [Related]

  • 6. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [Abstract] [Full Text] [Related]

  • 7. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER, Vogel R, Tipping R, Clineschmidt CM.
    Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
    [Abstract] [Full Text] [Related]

  • 8. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE, Friren B, International Brinzolamide Adjunctive Study Group.
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.
    Clineschmidt CM, Williams RD, Snyder E, Adamsons IA.
    Ophthalmology; 1998 Oct; 105(10):1952-9. PubMed ID: 9787369
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM, Williams RD, Snyder E, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J.
    Eur J Ophthalmol; 2000 Dec; 10(3):198-204. PubMed ID: 11071026
    [Abstract] [Full Text] [Related]

  • 12. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
    Heijl A, Strahlman E, Sverrisson T, Brinchman-Hansen O, Puustjärvi T, Tipping R.
    Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
    [Abstract] [Full Text] [Related]

  • 13. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM, Stewart RH, Stewart WC, Jia G, Smugar SS, Galet VA.
    Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
    [Abstract] [Full Text] [Related]

  • 14. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group.
    Lass JH, Khosrof SA, Laurence JK, Horwitz B, Ghosh K, Adamsons I.
    Arch Ophthalmol; 1998 Aug; 116(8):1003-10. PubMed ID: 9715679
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group.
    Hutzelmann JE, Polis AB, Michael AJ, Adamsons IA.
    Acta Ophthalmol Scand; 1998 Dec; 76(6):717-22. PubMed ID: 9881560
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.
    Rusk C, Sharpe E, Laurence J, Polis A, Adamsons I.
    Clin Ther; 1998 Dec; 20(3):454-66. PubMed ID: 9663361
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of dorzolamide, a topical carbonic anhydrase inhibitor, in combination with timolol in the treatment of patients with open-angle glaucoma and ocular hypertension.
    Hartenbaum D.
    Clin Ther; 1996 Dec; 18(3):460-5. PubMed ID: 8829021
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.
    Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA, COSOPT versus XALATAN Study Groups.
    Acta Ophthalmol Scand; 2004 Feb; 82(1):42-8. PubMed ID: 14982045
    [Abstract] [Full Text] [Related]

  • 19. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [Abstract] [Full Text] [Related]

  • 20. Comparison of latanoprost monotherapy to dorzolamide combined with timolol in patients with glaucoma and ocular hypertension.A 3-month randomised study.
    Emmerich KH.
    Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):19-23. PubMed ID: 10664047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.